Identification of novel prolyl oligopeptidase inhibitors from resin of Boswella papyrifera (Del.) Hochst. and their mechanism: Virtual and biochemical studies.
Boswella papyrifera
In vitro assay
Molecular docking
Molecular dynamic simulation
Prolyl oligopeptidase
Structure-based pharmacophore modeling
Virtual screening
Journal
International journal of biological macromolecules
ISSN: 1879-0003
Titre abrégé: Int J Biol Macromol
Pays: Netherlands
ID NLM: 7909578
Informations de publication
Date de publication:
31 Jul 2022
31 Jul 2022
Historique:
received:
18
01
2022
revised:
22
05
2022
accepted:
01
06
2022
pubmed:
10
6
2022
medline:
24
6
2022
entrez:
9
6
2022
Statut:
ppublish
Résumé
Prolyl endopeptidase or prolyl oligopeptidase (PEP or POP) is highly expressed in brain, and associated with autism spectrum disorders, dementia, aging and various psychological disorders, such as schizophrenia, mania, and neurodegeneration. To design highly potent and novel POP inhibitors, structure-based virtual screening was carried out using pharmacophore modeling and molecular docking studies. The docking based active compounds [incensole (1), incensole acetate (2), incensone (3), incensfuran (4), and epi-incensole acetate (5)] were selected and their dynamic behavior was studied through molecular dynamic simulation. Later, the top-ranked [predicted active, (1-5)] and lower-ranked [predicted in-active, (6-10)] compounds were tested by in-vitro assay. The in-vitro results showed that all top-ranked compounds (1-5) found significantly active against POP enzyme with IC
Identifiants
pubmed: 35679958
pii: S0141-8130(22)01195-3
doi: 10.1016/j.ijbiomac.2022.06.001
pii:
doi:
Substances chimiques
Enzyme Inhibitors
0
Resins, Plant
0
Prolyl Oligopeptidases
EC 3.4.21.26
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
751-767Informations de copyright
Copyright © 2022. Published by Elsevier B.V.